Osteoporosis: Pathogenesis and clinical intervention

Biochemical Society Transactions

Volumn 31, Issue 2, 2003, Pages 462-464

  Mueller, G ^a   Russell, R G G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aging; Bisphosphonates; Bone; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBANDRONIC ACID; INORGANIC PYROPHOSPHATASE; PARATHYROID HORMONE; PEPTIDE HORMONE; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; ZOLEDRONIC ACID;

AGED; AGING; BONE MASS; BREAST CANCER; CANCER RISK; CELL KINETICS; CLINICAL FEATURE; CONFERENCE PAPER; DRUG MECHANISM; FRACTURE; HEREDITY; HIGH RISK POPULATION; HUMAN; MUSCLE ATROPHY; MUSCULOSKELETAL SYSTEM; OSTEOARTHRITIS; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; POSTMENOPAUSE OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; UTERUS CANCER;

AGING; BONE REMODELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; OSTEOPOROSIS;

EID: 0037398076     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0310462     Document Type: Conference Paper

References (18)

1. The European prospective osteoporosis study (EPOS) group (2002) J. Bone Miner. Res. 17, 716-724
2. Ismail, A.A., Pye, S.R., Cockerill, W.C., Lunt, M., Silman, A.J., Reeve, J., Banzer, D., Benevolenskaya, L.I., Bhalla, A., Bruges Armas, J. et al. (2002) Osteoporosis Int. 13, 565-571
3. Cummings, S.R. and Melton, L.J. (2002) Lancet 359, 1761-1767
4. Torgerson, D.J. (2001) in The Effective Management of Osteoporosis, U.K. Key Advances in Clinical Practice (Barlow, D., ed), pp. 111-121, R. Miles Aesculapius Medical Press
5. Manolagas, S.C. (2000) Endocr. Rev. 21, 115-137
6. Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K.L., Armstrong, D., Ducy, P. and Karsenty, G. (2002) Cell 111, 305-317
7. Seeman, E. (2002) Lancet 359, 1841-1850
8. Boyden, L.M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M.A., Wu, D., Insogna, K. and Lifton, R.P. (2002) N. Engl. J. Med. 346, 1513-1521
9. Little, R.D., Carulli, J.P., Del Mastro, R.G., Dupuis, J., Osborne, M., Folz, C., Manning, S.P., Swain, P.M., Zhao, S.C., Eustace, B. et al. (2002) Am. J. Hum. Genet. 70, 11-19
10. Ralston, S.H. (2002) J. Clin. Endocrinol. Metab. 87, 2460-2466
11. Royal College of Physicians. Osteoporosis. Clinical guidelines for prevention and treatment. (1999) London
12. Royal CoLlege of Physicians, Bone and Tooth Society. Osteoporosis. Clinical guidelines for prevention and treatment. Update on pharmacological interventions and an algorithm for management. (2000) London
13. Delmas, P.D. (2002) Lancet 359, 2018-2025
14. Russell, R.G.G. and Rogers, M.J. (1999) Bone 25, 97-106
15. Reid, I.R., Brown, J.P., Burckhardt, P., Horowitz, Z., Richardson, P., Trechsel, U., Widmer, A., Devogelaer, J.P., Kaufman, J.M., Jaeger, P. N. Engl. J. Med. 346, 653-661
16. Neer, R.M., Arnaud, C.D., Zanchetta, J.R., Prince, R., Gaich, G.A., Reginster, J.Y., Hodsman, A.B., Eriksen, E.F, Ish-Shalom, S., Genant, H.K. et al. (2001) N. Engl. J. Med. 344, 1434-1441
17. Meunier, P.J., Slosman, D.O., Delmas, P.D., Sebert, J.L., Brandi, M.L., Albanese, C., Lorenc, R., Pors-Nielsen, S., De Vernejoul, M.C., Roces, A. and Reginster, J.Y. (2002) J. Clin. Endocrinol. Metab. 87, 2060-2066
18. Edwards, C.J., Russell, R.G.G. and Spector, T.D. (2001) Calcif. Tissue Int. 69, 63-66